Modulation of HIV Co-Receptor Expression on Cells by Anti-Virals

Daniel Y Adu

ISBN 10: 3844334246 / ISBN 13: 9783844334241

Published by LAP LAMBERT Academic Publishing Jun 2011, 2011

About this Item

This item is printed on demand - it takes 3-4 days longer - Neuware -It is the cell surface molecule receptor CD4 and the two chemokine co-receptors CCR5 and CXCR4 that allow the Human Immunodeficiency Virus (HIV) to enter and infect target cells; these are the direct or indirect targets of anti-retroviral drugs (ARV) currently being tested in clinical trials. No characterisation of the potential effect of these drugs on the level of expression of the receptor and/or co-receptors on the cell surface has, as of yet been performed. This is despite the existence of heterologous modulation of at least CCR5 by compounds which are structurally similar to some ARV drugs. We investigated whether candidate microbicides could modulate the expression of CD4, CCR5 and/or CXCR4 on the cell surface membrane of various cell types. Cell lines expressing different or unknown levels of co-receptors were incubated with entry inhibitors, reverse transcriptase inhibitors and protease inhibitors in a time course mode before assessment by flow cytometry. 92 pp. Englisch.

Seller Inventory # 9783844334241

Bibliographic Details

• Title: Modulation of HIV Co-Receptor Expression on Cells by Anti-Virals
• Publisher: LAP LAMBERT Academic Publishing Jun 2011
• Publication Date: 2011
• Language: English
• ISBN 10: 3844334246
• ISBN 13: 9783844334241
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 220W x 150H x 6D millimeters 220 millimeters width by 150 millimeters height by 6 millimeters depth
• Weight: 155 grams

About this title

Synopsis

It is the cell surface molecule receptor CD4 and the two chemokine co-receptors CCR5 and CXCR4 that allow the Human Immunodeficiency Virus (HIV) to enter and infect target cells; these are the direct or indirect targets of anti-retroviral drugs (ARV) currently being tested in clinical trials. No characterisation of the potential effect of these drugs on the level of expression of the receptor and/or co-receptors on the cell surface has, as of yet been performed. This is despite the existence of heterologous modulation of at least CCR5 by compounds which are structurally similar to some ARV drugs. We investigated whether candidate microbicides could modulate the expression of CD4, CCR5 and/or CXCR4 on the cell surface membrane of various cell types. Cell lines expressing different or unknown levels of co-receptors were incubated with entry inhibitors, reverse transcriptase inhibitors and protease inhibitors in a time course mode before assessment by flow cytometry.

About the Author

Daniel Yaw Adu BSc(Hons),MRes born in London in 1987 entered the Masters of Research program at St George’s University of London to pursue his medical interests. This thesis was based on his Masters project. This thesis was typed by the author. Contact: daniel.adu@hotmail.co.uk